Bailard Inc. Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN)
Bailard Inc. boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.6% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 39,772 shares of the medical research company’s stock after purchasing an additional 609 shares during the quarter. Bailard Inc.’s […]